Prostate cancer in advanced stage has spread, the survival period cannot be generalized, the 5-year survival rate is only about 30%, the survival period is mainly related to whether the treatment is timely or not, the immunity of the body, whether the treatment is standardized and other factors. In the advanced stage of prostate cancer, blood flow may occur, or directly invade the seminal vesicles, bladder and other neighboring organs, and may also metastasize to lymph nodes, bones, lungs, liver, adrenal glands and other parts of the body. The 5-year survival rate of advanced patients is low, only about 30%, and is also closely related to whether the patient is treated in time, the body’s immunity, whether the treatment is standardized and other factors. Generally speaking, if patients are treated in time, they may survive for about 5 years, and if they are not actively treated, the survival time will be shortened. If the patient’s immunity is low, the survival time will be relatively shorter. At the same time, if the patient’s treatment is not standardized, it will lead to aggravation of the disease or prolonged treatment, which will also lead to shorter survival time. It is recommended that prostate cancer patients follow the doctor’s instructions for targeted treatment and do a good job of daily care, so as to prolong the survival time.